View in EDS HTML Full Text PDF Full Text

SCORT–Cas13d Nanotherapy Precisely Targets the 'Undruggable' Transcription Factor HoxB13 in Metastatic Prostate Cancer In Vivo.

Saved in:
Bibliographic Details
Title: SCORT–Cas13d Nanotherapy Precisely Targets the 'Undruggable' Transcription Factor HoxB13 in Metastatic Prostate Cancer In Vivo.
Authors: Cui, Zhifen1 (AUTHOR), Huang, Furong1 (AUTHOR), Fang, Kun2 (AUTHOR), Yan, Jingyue3 (AUTHOR), Zhang, Yuebao3 (AUTHOR), Kang, Diana D.3,4 (AUTHOR), Zhou, Yufan5 (AUTHOR), Zhao, Yue1 (AUTHOR), Everitt, Jeffrey I.1 (AUTHOR), Hankey, William1 (AUTHOR), Armstrong, Andrew J6,7 (AUTHOR), Huang, Jiaoti1 (AUTHOR), Wang, Hongyan1 (AUTHOR), Jin, Victor X.2 (AUTHOR), Dong, Yizhou4 (AUTHOR) yizhou.dong@mssm.edu, Wang, Qianben1,7,8 (AUTHOR) qianben.wang@duke.edu
Source: Advanced Science. 6/20/2025, Vol. 12 Issue 23, p1-19. 19p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:21983844
DOI:10.1002/advs.202417605